Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Erlotinib: preclinical investigations.
Manuel Hidalgo
Research output
:
Contribution to journal
›
Review article
›
peer-review
37
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Erlotinib: preclinical investigations.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Erlotinib Hydrochloride
100%
Protein-Tyrosine Kinases
26%
Capecitabine
24%
gemcitabine
21%
Bevacizumab
21%
Non-Small Cell Lung Carcinoma
17%
epidermal growth factor receptor VIII
15%
TP protocol
13%
Neoplasms
12%
Mitogen-Activated Protein Kinase Kinases
10%
Doxorubicin
9%
Inhibitory Concentration 50
8%
Heterografts
8%
Phosphotransferases
7%
Radiotherapy
6%
Growth
4%